|
⚲
|
| Keyboard |
| Poukalov Konstantin
✚
|
|
|---|---|
| CIK # | 0001678736 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001678736] | |
| 4 | [0001678736] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lyra Therapeutics Inc LYRA
Stock Option · derivative
|
2024-06-13 | Grant | 30,000 | $0.00 | |
|
LianBio LIAN
Ordinary Shares
|
2024-02-15 | Option exercise | 36,300 | $2.52 | 91,476 |
|
LianBio LIAN
Ordinary Shares
|
2024-02-15 | Tax withheld | 19,218 | $4.76 | 91,478 |
|
LianBio LIAN
Stock Option (Right to Buy) · derivative
|
2024-02-15 | Option exercise | 36,300 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Stock Option · derivative
|
2023-06-30 | Grant | 20,000 | $0.00 | |
|
LianBio LIAN
Stock Option (Right to Buy) · derivative
|
2023-06-21 | Grant | 36,300 | $0.00 | |
|
LianBio LIAN
Stock Option (Right to Buy) · derivative
|
2022-06-23 | Grant | 36,300 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Stock Option · derivative
|
2022-06-16 | Grant | 7,250 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Stock Option · derivative
|
2021-05-26 | Grant | 7,250 | $0.00 | |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-09 | Buy | 34,951 | $14.60 | 510,285 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-09 | Buy | 64,730 | $13.80 | 893,274 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 1,250,000 | $16.00 | 20,000,000 |
|
Landos Biopharma Inc LABP
Series A Preferred Stock · derivative
|
2021-02-08 | Conversion | 5,883,538 | ||
|
Landos Biopharma Inc LABP
Series B Preferred Stock · derivative
|
2021-02-08 | Conversion | 7,486,190 | ||
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 34,611 | $11.38 | 393,873 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 86,671 | $12.53 | 1,085,988 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 1,771 | $13.10 | 23,200 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Conversion | 13,369,728 | ||
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-05 | Buy | 27,453 | $11.14 | 305,826 |
|
Lyra Therapeutics Inc LYRA
Stock Option · derivative
|
2020-04-30 | Grant | 14,500 | $0.00 | |
| showing 20 of 26 most recent transactions | |||||